Operating Lease, Right-of-Use Asset of KalVista Pharmaceuticals, Inc. from 31 Jul 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
KalVista Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Jul 2019 to 30 Sep 2025.
  • KalVista Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $9,096,000, a 55% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $9,096,000 +$3,233,000 +55% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $5,165,000 -$694,000 -12% 31 Jul 2025 10-Q 11 Sep 2025 2026 Q1
Q1 2025 $5,544,000 -$1,376,000 -20% 30 Apr 2025 10-Q 11 Sep 2025 2026 Q1
Q4 2024 $5,574,000 -$1,471,000 -21% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $5,863,000 -$1,435,000 -20% 31 Oct 2024 10-Q 05 Dec 2024 2025 Q2
Q2 2024 $5,859,000 -$1,712,000 -23% 31 Jul 2024 10-Q 05 Sep 2024 2025 Q1
Q1 2024 $6,920,000 -$902,000 -12% 30 Apr 2024 10-K 10 Jul 2025 2025 FY
Q4 2023 $7,045,000 -$1,056,000 -13% 31 Jan 2024 10-Q 11 Mar 2024 2024 Q3
Q3 2023 $7,298,000 -$1,067,000 -13% 31 Oct 2023 10-Q 07 Dec 2023 2024 Q2
Q2 2023 $7,571,000 -$1,093,000 -13% 31 Jul 2023 10-Q 07 Sep 2023 2024 Q1
Q1 2023 $7,822,000 -$40,000 -0.51% 30 Apr 2023 10-K 11 Jul 2024 2024 FY
Q4 2022 $8,101,000 -$79,000 -0.97% 31 Jan 2023 10-Q 09 Mar 2023 2023 Q3
Q3 2022 $8,365,000 +$1,406,000 +20% 31 Oct 2022 10-Q 08 Dec 2022 2023 Q2
Q2 2022 $8,664,000 +$1,457,000 +20% 31 Jul 2022 10-Q 08 Sep 2022 2023 Q1
Q1 2022 $7,862,000 +$2,104,000 +37% 30 Apr 2022 10-K 10 Jul 2023 2023 FY
Q4 2021 $8,180,000 +$6,527,000 +395% 31 Jan 2022 10-Q 10 Mar 2022 2022 Q3
Q3 2021 $6,959,000 +$5,654,000 +433% 31 Oct 2021 10-Q 09 Dec 2021 2022 Q2
Q2 2021 $7,207,000 +$5,727,000 +387% 31 Jul 2021 10-Q 09 Sep 2021 2022 Q1
Q1 2021 $5,758,000 +$4,146,000 +257% 30 Apr 2021 10-K 07 Jul 2022 2022 FY
Q4 2020 $1,653,000 +$156,000 +10% 31 Jan 2021 10-Q 11 Mar 2021 2021 Q3
Q3 2020 $1,305,000 -$329,000 -20% 31 Oct 2020 10-Q 10 Dec 2020 2021 Q2
Q2 2020 $1,480,000 -$257,000 -15% 31 Jul 2020 10-Q 14 Sep 2020 2021 Q1
Q1 2020 $1,612,000 30 Apr 2020 10-K 13 Jul 2021 2021 FY
Q4 2019 $1,497,000 31 Jan 2020 10-Q 10 Mar 2020 2020 Q3
Q3 2019 $1,634,000 31 Oct 2019 10-Q 03 Dec 2019 2020 Q2
Q2 2019 $1,737,000 31 Jul 2019 10-Q 09 Sep 2019 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.